NOXO1
NADPH oxidase organizer 1
Also known as: NOXO1_HUMAN, P41NOXA, P41NOXB, P41NOXC, SH3PXD5, SNX28
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NFA2
- Gene
- NOXO1
- Ensembl
- ENSG00000196408
- Chromosome
- 16
- Canonical length
- 376 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes an NADPH oxidase (NOX) organizer, which positively regulates NOX1 and NOX3. The protein contains a PX domain and two SH3 domains. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2012]
Canonical amino-acid sequenceUniProt
376 residues, UniProt reviewed canonical sequence.
>Q8NFA2|NOXO1
1 MAGPRYPVSV QGAALVQIKR LQTFAFSVRW SDGSDTFVRR SWDEFRQLKK TLKETFPVEA
61 GLLRRSDRVL PKLLGQASLD APLLGRVGRT SRGLARLQLL ETYSRRLLAT AERVARSPTI
121 TGFFAPQPLD LEPALPPGSR VILPTPEEQP LSRAAGRLSI HSLEAQSLRC LQPFCTQDTR
181 DRPFQAQAQE SLDVLLRHPS GWWLVENEDR QTAWFPAPYL EEAAPGQGRE GGPSLGSSGP
241 QFCASRAYES SRADELSVPA GARVRVLETS DRGWWLCRYG DRAGLLPAVL LRPEGLGALL
301 SGTGFRGGDD PAGEARGFPE PSQATAPPPT VPTRPSPGAI QSRCCTVTRR ALERRPRRQG
361 RPRGCVDSVP HPTTEQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NOXO1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 8.1 nTPM
Expression across tissuesHPA
Tissue
- colon: 8.1 nTPM
- rectum: 5.5 nTPM
- cerebellum: 5.4 nTPM
- testis: 4.6 nTPM
- appendix: 4.4 nTPM
- small intestine: 3.2 nTPM
Single-cell type
- esophageal apical cells: 93 nCPM
- breast lactating cells: 54 nCPM
- colonocytes: 52 nCPM
- enteric stem cells: 30 nCPM
- submucosal glandular cells: 27 nCPM
- enteric transient amplifying cells: 27 nCPM
Immune cell
- basophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 3.8 nTPM
- cerebral cortex: 2.8 nTPM
- choroid plexus: 2.4 nTPM
- basal ganglia: 2.1 nTPM
- cerebellum: 2 nTPM
- white matter: 2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.62
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.81
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- extracellular matrix disassembly
- regulation of hydrogen peroxide metabolic process
- regulation of respiratory burst
- superoxide anion generation
Molecular functions
- enzyme binding
- phosphatidylinositol binding
- phospholipid binding
- superoxide-generating NADPH oxidase activator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SH3 domain
- Phox homology
- SH3-like domain superfamily
- PX domain superfamily
- NADPH Oxidase and PX Domain-Containing
- SH3 domain
- NADPH oxidase organiser 1, second SH3 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NOXO1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NOXO1 as an antibody target. Whether an autoantibody or antibody against NOXO1 could matter depends on whether native NOXO1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NOXO1 is annotated at the cell surface, where native NOXO1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label NOXO1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...